NCT04403373
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- Li Kai Shing Faculty of Medicine Hong Kong, Southern District
Clinical trial condition
Major Depressive Disorder (MDD)
Explore clinical trials studying Major Depressive Disorder (MDD). Study availability and eligibility vary by location and protocol.
166 public trials
63 recruiting studies
Major Depressive Disorder (MDD) trial results
Completed
Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
NCT00411242
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Novartis Investigative Site Mesa, Arizona, United States
- Novartis Investigative Site Los Angeles, California, United States
- Novartis Investigative Site Oceanside, California, United States
- Novartis Investigative Site San Diego, California, United States
NCT02109939
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- Birmingham Psychiatry Pharmaceutical Studies Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- CiTrials Bellflower, California, United States
- Catalina Research Institute Chino, California, United States
NCT02380066
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- Anhui province hospital of TCM Hefei, Anhui, China
- Guang'anmen Hospital Beijing, Beijing Municipality, China
- Peking University Sixth Hospital Beijing, Beijing Municipality, China
- Guangzhou Huiai Hospital Guangzhou, Guangdong, China
NCT01683019
- Conditions
- Behavior, Behavioral Symptoms, Depression, +5 more
- Locations
-
- Amen Clinic Newport Beach, California, United States
- Institute of Mental Health, Peking University Beijing, China
NCT01253421
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- McLean Hospital Belmont, Massachusetts, United States
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chino, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, California, United States
Completed
European Drug Utilization Study
NCT01594996
- Conditions
- Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +2 more
- Locations
-
- Research Site Dortmund, Germany
NCT00316160
- Conditions
- Behavior, Behavioral Symptoms, Depression, +8 more
- Locations
-
- GSK Investigational Site Mesa, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Scottsdale, Arizona, United States
- GSK Investigational Site Little Rock, Arkansas, United States
Completed
Lethargic Depression Study
NCT00064467
- Conditions
- Behavior, Behavioral Symptoms, Brain Diseases, +16 more
- Locations
-
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site Sherman Oaks, California, United States
- GSK Investigational Site Temecula, California, United States
- GSK Investigational Site Denver, Colorado, United States